Q3 2018 Holdings
Filed 2018-11-14 | 113 holdings | $76.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $15.8M | 1,142,089 | 20.6% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $12.6M | 447,970 | 16.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $10.3M | 136,381 | 13.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.5M | 88,000 | 11.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $6.6M | 92,673 | 8.6% |
| Cisco SYS Inc(CSCO) | COM | 17275R102 | $4.9M | 100,000 | 6.3% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $4.3M | 233,151 | 5.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.0M | 240,000 | 5.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $3.5M | 40,000 | 4.6% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.8M | 321,430 | 3.6% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $1.7M | 95,300 | 2.2% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $462.0K | 1,419 | 0.6% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $378.0K | 40,000 | 0.5% |
| Spdr Series Trust(XBI)Put | PUT | 78464A870 | $105.5K | 1,100,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $55.3K | 780,000 | 0.1% |
| Mylan N V | SHS EURO | N59465109 | $48.5K | 1,325,000 | 0.1% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $44.9K | 325,000 | 0.1% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $34.7K | 865,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $33.5K | 540,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $32.4K | 420,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $21.6K | 1,787,994 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $19.7K | 141,700 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $15.0K | 859,727 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $14.6K | 699,039 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $12.3K | 76,116 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $11.4K | 78,396 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $11.4K | 2,005,243 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $10.6K | 842,391 | 0.0% |
| Caesarstone LTD(CSTE) | ORD SHS | M20598104 | $10.4K | 561,311 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $9.9K | 210,000 | 0.0% |
| Retrophin Inc | COM | 761299106 | $9.4K | 325,678 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $8.9K | 296,251 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $8.5K | 60,000 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $8.0K | 69,656 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $7.7K | 398,749 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $7.6K | 296,856 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $7.6K | 92,719 | 0.0% |
| Verint SYS Inc(VTY) | COM | 92343X100 | $7.5K | 150,126 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $7.1K | 1,154,690 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $6.5K | 177,849 | 0.0% |
| Melinta Therapeutics Inc | COM | 58549G100 | $6.4K | 1,616,867 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $6.3K | 653,112 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $6.1K | 255,930 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $6.1K | 40,401 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $6.0K | 395,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $5.8K | 155,515 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $5.7K | 1,179,010 | 0.0% |
| Solaredge Technologies Inc(SEDG) | COM | 83417M104 | $5.7K | 150,817 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $5.6K | 245,104 | 0.0% |
| Wabtec Corp(WAB) | COM | 929740108 | $5.6K | 53,114 | 0.0% |